Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia (2024) Goebell P, Raina R, Chen S, Rege S, Shah R, Grossman JP, Waldeck AR Journal article Association between event-free survival and overall survival in early-stage triple-negative breast cancer (2024) Huang M, Fasching P, Haiderali A, Xue W, Pan W, Karantza V, Yang F, et al. Journal article, Review article Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors (2023) Dromain C, Pavel ME, Ronot M, Schaefer N, Mandair D, Gueguen D, Cheng C, et al. Journal article The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors (2023) Pavel ME, Dromain C, Ronot M, Schaefer N, Mandair D, Gueguen D, Elvira D, et al. Journal article Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma (2020) Goebell P, Ivanyi P, Bedke J, Bergmann L, Berthold D, Boegemann M, Busch J, et al. Journal article, Review article Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go (2019) Gevaert T, Cimadamore A, Eckstein M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R Journal article, Review article IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug? (2018) Amoroso V, Pavel ME, Claps M, Roca E, Ravanelli M, Maroldi R, Oberg K, Berruti A Journal article The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape (2017) Goebell P, Doehn C, Gruellich C, Gruenwald V, Steiner T, Ehness R, Welslau M Journal article Molecular pathology of mixed-lineage leukemia (2009) Bach C, Slany R Journal article, Review article